InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[JB3729]

I don't see NVIV share holders voting for this buy out proposal. However, if I were a NVIV share holder I would be concerned about the patent rights -

· Terrible Stock Performance, Terrible CEO, and Terrible Board of Directors 2013-2017
· Without conducting an exit interview of NVIV Founder, NVIV primary NeuroScaffold inventor and patent holder Frank Reynolds, NVIV shareholders have struggled to maintain the $520,000,000 in value created by Frank Reynolds, and today at $136mm they are dreadfully overvalued.
· It took years for NVIV to notify Frank Reynolds of their patent assignment issue, and Frank Reynolds will not provide FREE patents to NVIV. That request was ridiculous.
· There’s never been a bridge for NVIV shareholders to own the commercial rights to the original Neuroscaffold and Frank Reynolds and PXRB can provide that to NVIV shareholders.